Halal Pharmaceuticals 2018 Global Market Key Players – Malaysia Berhad, Rosemont Pharmaceuticals, Bosch Pharmaceuticals, Noor Vitamins, EMBIL Pharmaceutical Co., Ltd, Nutramedica Incorporated, Pharmaniaga Bhd, and Simpor Pharma Sdn Bhd

The global halal pharmaceuticals market is expected to grow from USD 21.22 billion in 2017 to USD 34.82 billion by 2026, at a CAGR of 5.7% during the forecast period according to a study published by Polaris Market Research.

Primary factor driving the halal pharmaceuticals market growth is the growing demand for non-halal item by rapidly increasing Muslim population across the globe. Furthermore, the increasing awareness and strict adherence to purity standards is making the end products quiet attractive to both Muslim and non-Muslim customers. The halal pharmaceuticals market is experiencing significant increase in the population of vegans, along with Islam followers which is consequently affecting the adoption of halal pharmaceuticals. This can be primarily attributed to the fact that they do not contain any traces of alcohol, animal or non-halal ingredients.

Request sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/halal-pharmaceuticals-market/request-for-free-sample

Halal pharmaceuticals prohibit the use of any non-halal ingredient that comprises traces or substances derived from animals such as dog, and pigs, among others. In addition, Sharian law forbids usage and intake of collagen, glycerin, and allantoin, among others. Moreover, these pharmaceuticals cannot to be tested on innocent animals such as rabbits, monkey or any other animals.

Major Key Player In Global Player: -

Chemical Company of Malaysia Berhad
Rosemont Pharmaceuticals
Bosch Pharmaceuticals
Noor Vitamins
EMBIL Pharmaceutical Co. Ltd
Nutramedica Incorporated
PharmaniagaBhd
SimporPharmaSdnBhd.

Regulations and standardization in the industry pose a great challenge as regulatory bodies and pharmaceutical associations present across the globe have difference in opinions. For instance, recently, American pharmaceuticals companies expressed their concerns over the guidelines by Malaysia’s Ministry of Health (MOH). These guidelines were focused towards defining the permissible items in pharmaceuticals in accordance with Islam. The concern was highlighted in the annual submission to the United States Trade Representative by the Pharmaceutical Researchers and Manufacturers of America (PhRMA).

Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/halal-pharmaceuticals-market/inquire-before-buying

The Middle East and the Asia Pacific regions halal pharmaceuticals market are expected to witness significant growth in the next eight years due to the presence of a large population of Muslims. Majority of the Muslim population of the world lives in these regions, and they also comprise of emerging nations such as India, Indonesia, Malaysia, Bangladesh, Maldives, and Pakistan that have a high population that follows Islamic beliefs.

The report provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the Global Halal Pharmaceuticals Market, 2017-2026. The halal pharmaceuticals market report comprises a detailed geographic distribution of the market across North America, Europe, APAC and South America, and MEA. North America is further segmented into U.S., Canada. Europe is divided into Germany, UK, Italy, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, and Rest of Asia-Pacific.

Competitive Landscape and Key Vendors

Global halal pharmaceuticals market is characterized by the presence of a large supplier base, comprising numerous well established as well as regional, and local players. However, the market is mainly dominated by large international players that are continuously striving to introduce innovation in their products. They are investing heavily on research & development, in order to come up with more technologically advanced products. Through these initiatives, these players are trying to maintain and improve their existing market positions.

Browse Complete Report Details @ https://www.polarismarketresearch.com/industry-analysis/halal-pharmaceuticals-market/

Key Segments

Drug Class
• Allergies
• Endocrine Drugs
• Pain Medications
• Respiratory Drugs
• Others
Product Type
• Capsule
• Syrup
• Tablet
Application
• Healthcare
• Drug
• Cosmetics
Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Rest of Europe
• Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
• South America
o Brazil
o Rest of Latin America

Middle East and Africa.

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us-

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.